{
    "nctId": "NCT00959244",
    "briefTitle": "Study of Urine Samples From Women With Newly Diagnosed Breast Cancer Enrolled on Clinical Trial UNMC-08105",
    "officialTitle": "1) Effects of Therapeutic Agents on Estrogens in the Breast 2) Utilizing the Resources of the Breast Cancer Collaborative Registry (BCCR)",
    "overallStatus": "COMPLETED",
    "conditions": "Breast Cancer",
    "studyType": "OBSERVATIONAL",
    "phase": "N/A",
    "allocation": "N/A",
    "primaryPurpose": "N/A",
    "enrollmentCount": 100,
    "primaryOutcomeMeasure": "Estrogen compounds",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Newly diagnosed ductal carcinoma in situ or invasive breast cancer\n* Urine biospecimens available from participation in protocol UNMC-08105 (IRB#311-06), the Breast Cancer Collaborative Registry (BCCR), which included treatment with tamoxifen or an aromatase inhibitor\n\n  o Urine specimens were collected at baseline, 6 months, and then annually\n* Estrogen receptor or progesterone receptor positive\n* ECOG performance status 0-2\n\nExclusion Criteria:\n\n* Not pregnant or nursing\n* No concurrent use of estrogen(s)",
    "sex": "FEMALE",
    "minimumAge": "19 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}